Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2006

01-06-2006 | Epidemiology

Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women

Authors: George Pentheroudakis, George Fountzilas, Dimitrios Bafaloukos, Vasiliki Koutsoukou, Dimitrios Pectasides, Dimosthenis Skarlos, Epaminondas Samantas, Haralabos P. Kalofonos, Helen Gogas, Nicholas Pavlidis

Published in: Breast Cancer Research and Treatment | Issue 3/2006

Login to get access
Metadata
Title
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women
Authors
George Pentheroudakis
George Fountzilas
Dimitrios Bafaloukos
Vasiliki Koutsoukou
Dimitrios Pectasides
Dimosthenis Skarlos
Epaminondas Samantas
Haralabos P. Kalofonos
Helen Gogas
Nicholas Pavlidis
Publication date
01-06-2006
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-005-9117-4

Other articles of this Issue 3/2006

Breast Cancer Research and Treatment 3/2006 Go to the issue

Epidemiology

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer

Preclinical study

Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells

Report

Positive predictive value of breast fine needle aspiration cytology (FNAC) in combination with clinical and imaging findings: a series of 2334 subjects with abnormal cytology

Clinical trial

Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients

Epidemiology

Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients

Preclinical study

The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits